Sleep Apnea Symptoms Eased With Implantable Stimulation Device, University of Pennsylvania School of Medicine Study
A New study holds promise for people with moderate to severe obstructive sleep apnea who are unable to tolerate standard therapy, after finding that an implantable, nerve-stimulating device successfully eased symptoms of the condition.
Lead author Dr. Richard Schwab, co-medical director of the Sleep Center at the University of Pennsylvania School of Medicine, and colleagues recently presented their findings at SLEEP 2016 - the 30th annual meeting of the Associated Professional Sleep Societies LLC, held in Denver, CO.
Obstructive sleep apnea (OSA) is estimated to affect more than 18 million adults in the United States, with men at greater risk than women.
Lead author Dr. Richard Schwab, co-medical director of the Sleep Center at the University of Pennsylvania School of Medicine, and colleagues recently presented their findings at SLEEP 2016 - the 30th annual meeting of the Associated Professional Sleep Societies LLC, held in Denver, CO.
Obstructive sleep apnea (OSA) is estimated to affect more than 18 million adults in the United States, with men at greater risk than women.